ArticleCancers2020

Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab.

Romain-David Seban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.